Application 220225
- Type
- ANDA
- Sponsor
- ALEMBIC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | METHOTREXATE SODIUM | METHOTREXATE SODIUM | INJECTABLE;INJECTION | EQ 50MG BASE/2ML (EQ 25MG BASE/ML) | No | No |
| 002 | METHOTREXATE SODIUM | METHOTREXATE SODIUM | INJECTABLE;INJECTION | EQ 1GM BASE/40ML (EQ 25MG BASE/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220225-001 | METHOTREXATE SODIUM | METHOTREXATE SODIUM | EQ 50MG BASE/2ML (EQ 25MG BASE/ML) | INJECTABLE / INJECTION | AP | 2026-04-15 | |
| A220225-002 | METHOTREXATE SODIUM | METHOTREXATE SODIUM | EQ 1GM BASE/40ML (EQ 25MG BASE/ML) | INJECTABLE / INJECTION | AP | 2026-04-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220225-001 | AP |
| A220225-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220225-001 | METHOTREXATE SODIUM | EQ 50MG BASE/2ML (EQ 25MG BASE/ML) | INJECTABLE / INJECTION | AP | 2026-04-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220225-002 | METHOTREXATE SODIUM | EQ 1GM BASE/40ML (EQ 25MG BASE/ML) | INJECTABLE / INJECTION | AP | 2026-04-15 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220225-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220225-002 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| METHOTREXATE | METHOTREXATE | Alembic Pharmaceuticals Inc. | a63364d5-4dfa-49d7-8a5e-c8959ae1d37a | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | 220225 ANDA220225 |
| METHOTREXATE | METHOTREXATE | Alembic Pharmaceuticals Limited | e98b2abd-8068-482e-9ce3-1ab262f0838e | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | 220225 ANDA220225 |